Hoge Stephen

Hoge Stephen serves as the President of Moderna, Inc., a leading biotechnology company known for its mRNA technology and vaccine development. His insider trading disclosures, tracked through SEC Form 4 filings, reveal a pattern of sale activity within the firm, specifically focusing on Moderna (MRNA). Between February 10, 2025, and July 16, 2026, he reported three sales totaling between $3.6 million and $308.5 thousand, with the largest transaction occurring on February 25, 2026, amounting to approximately $7.8 million.